Patogenesis-2

Embed Size (px)

Citation preview

  • 8/9/2019 Patogenesis-2

    1/37

    Viral Pathogenesis

  • 8/9/2019 Patogenesis-2

    2/37

    Viral Pathogenesis

    Viral pathogenesis is the process by which a viral infection

    leads to disease.

    Viral pathogenesis is an abnormal situation of no value tothe virus.

    The majority of viral infections are subclinical. It is not in

    the interest of the virus to severely harm or kill the host.

    The consequences of viral infections depend on theinterplay between a number of viral and host factors.

  • 8/9/2019 Patogenesis-2

    3/37

    PATOGENESIS PENYAKIT VIRUS

    PRINSIP : Terjadi siklus replikasi virus dalam sel hospesRespon imunseluler SitopatologiKematian, hiperplasia, kanker, tidak

    terjadi apa-apa

    Infeksi Viruspenyakit virusabnormalitas struktur!fungsi"

    #Subklinik : infeksi dengan gejala tidak nyata#Klinik : infeksi dengan gejala $ tanda

    Virus patogenmampu menginfeksi $ menyebabkan penyakit

    Strain virulen strain yang lebih sering menyebabkan penyakit dibandingkan

    strain lain

    EFEK SITOPATIK (ESP)VIRUS SEL HOSPES PEKA

  • 8/9/2019 Patogenesis-2

    4/37

    utcome of Viral Infection

    Acute Infection

    ! "ecovery with no residue effects

    ! "ecovery with residue effects e.g. acute viral encephalitis leading to

    neurological sequelae.! #eath

    ! Proceed to chronic infection

    Chronic Infection

    ! $ilent subclinical infection for life e.g. %&V' ()V

    ! * long silent period before disease e.g. +IV' $$P(' P&,

    ! "eactivation to cause acute disease e.g. herpes and shingles.

    ! %hronic disease with relapses and e-cerbations e.g. +)V' +%V.

    ! %ancers e.g. ()V' +T,V/' +PV' +)V' +%V' ++V0

  • 8/9/2019 Patogenesis-2

    5/37

    1actors in Viral Pathogenesis (ffects of viral infection on cells 2%ellular

    Pathogenesis3

    (ntry into the +ost

    %ourse of Infection 2Primary "eplication' $ystemic

    $pread' $econdary "eplication3

    %ell4Tissue Tropism

    %ell4Tissue #amage

    +ost Immune "esponse

    Virus %learance or Persistence

  • 8/9/2019 Patogenesis-2

    6/37

    %ellular Pathogenesis

    %ells can respond to viral infections in 5 ways6 2/3 7o apparent change'283 #eath' and 253 Transformation

    #irect cell damage and death from viral infection may result from

    ! diversion of the cell9s energy! shutoff of cell macromolecular synthesis

    ! competition of viral m"7* for cellular ribosomes

    ! competition of viral promoters and transcriptional enhancers for cellulartranscriptional factors such as "7* polymerases' and inhibition of theinterferon defense mechanisms.

    Indirect cell damage can result from! integration of the viral genome

    ! induction of mutations in the host genome

    ! inflammation

    ! host immune response.

  • 8/9/2019 Patogenesis-2

    7/37

    REPRODUKSI VIRUS DALAMBIAKAN SEL :

    # Adanya ESP Polioy!li"i#$Va%i&!lla$ H!%'!# Si'l!$ H!%'!#oo#"!%$ Mo%*ili$ M+'#$In,l+!n-a$ D!n.+!$ E&/o0i%+#$

    1o#a&2i!0i%+#$ 1y"o!.alo0i%+## Adanya /a*a"an !"a*oli#!

    #!l Polioy!li"i#$ E&/o0i%+#$Ad!no0i%+# 1o#a&2i!0i%+#

    # Adanya '!*!n"+2an/!a.l+"inin Vi%+# In,l+!n-a$Pa%o"i"i# !'id!i&a$ E&/o0i%+#$1o#a&2i!0i%+#

    # Adanya '%o#!# /!ad#o%'#iVi%+# Pa%ain,l+!n-a

    # Adanya '!%+*a/an o%,olo.i2 #!lVi%+# Sa%&oa Ro+#$ Siian

    Vi%+# 34 (SV 34)

    ESP (1YTOPATHI1 EFFE1T) :

    # P!n..!*+n.an #'" *alon# Pla#oli#i## Pi2no#i## Ka%yo%!2#i## P!*!n"+2an #in#i"i+# P!*!n"+2an #!l %a2#a#a *!%in"i

    *anya2 (M+l"in+&l!a"!d Gian" 1!llFo%a"ion)

    # Va2+oli#a#i5P!*!n"+2an #!l *+#a

    (Foay 1!ll Fo%a"ion)# N!2%o#i#5'!n.!%+"an# P!*!n"+2an *adan in2l+#i

    (In&l+#ion Body Fo%a"ion)

  • 8/9/2019 Patogenesis-2

    8/37

    TIPE ESP PADA SEL HOSPES

    Bia2an S!l No%al Vi%+#

    P!n..!*+n.an

    Pla#oli#i#

    Va2+oli#a#i5S!l *+#a

    Pi2no#i#

    Sin#i"i+5S!l %a2#a#a

    Badan In2l+#i

    Ka%yo%!2#i#

    N!2%o#i#5!n.!%+"

  • 8/9/2019 Patogenesis-2

    9/37

    Viral (ntry

    Skin &ost viruses which infect via the skin require a breach in thephysical integrity of this effective barrier' e.g. cuts or abrasions. &anyviruses employ vectors' e.g. ticks' mosquitos or vampire bats to breachthe barrier.

    Conjunctiva and other mucous membranes rather e-posed site andrelatively unprotected

    Respiratory tract In contrast to skin' the respiratory tract and all othermucosal surfaces possess sophisticated immune defence mechanisms' aswell as nonspecific inhibitory mechanisms 2cilliated epithelium' mucussecretion' lower temperature3 which viruses must overcome.

    Gastrointestinal tract a hostile environment: gastric acid' bile salts'etc. Viruses that spread by the ;I tract must be adapted to this hostileenvironment.

    Genitourinary tract relatively less hostile than the above' but lessfrequently e-posed to e-traneous viruses 2

  • 8/9/2019 Patogenesis-2

    10/37

    JALUR ASU! "IRUS #A$A #%RU!AA& 'U(U)

  • 8/9/2019 Patogenesis-2

    11/37

    6ALUR UMUM INFEKSI VIRUS

    6al+% Ma#+2 K!lo'o2 Vi%+# G!7ala lo2al 'ada "!'a" a#+2In,!2#i !ny!l+%+/ dan'!nya2i" o%.an 2/+#+#

    Sal+%an P!%na'a#an Ad!no0i%+#

    H!%'!#0i%+#

    Po0i%+#

    Pi2o%na0i%+#

    To.a0i%+#

    O%"iyo0i%+#

    Pa%ayo0i%+#

    1o%ona0i%+#

    K!*anya2an S'!#i!#

    E'#"!in Ba%%$H!%'!# #i'l!

    8

    Rino0i%+#

    8

    In,l+!n-a

    Pa%ain,l+!n-a$ 0i%+# Sin#i"ial

    '!%na'a#an

    K!*anya2 S'!#i!#

    8

    Va%i&!lla

    1a&a% ('+na/)

    B!*!%a'a En"!%o0i%+#

    R+*!la

    8

    Gondon.$ 1a'a2

    8

    M+l+" dan Sal+%an U#+# Ad!no0i%+#

    H!%'!#0i%+#

    Pi2o%na0i%+#

    R!o0i%+#

    B!*!%a'a #'!#i!#

    E'#"!in Ba%%$H!%'!#i'l!

    8

    Ro"a0i%+#

    8

    1y"o!.alo0i%+#

    B*%' En"!%o0i%+#$ Polio dan

    H!'a"i"i# A

    8

    K+li"

    L+2a %in.an

    T+#+2an

    Gi.i"an

    Pa'o0a0i%+#

    H!%'!#0i%+#

    Po0i%+#H!%'!# 0i%+#

    H!'adna0i%+#

    R!"%o0i%+#

    Ra*do0i%+#

    To.a0i%+#

    Fla0i0i%+#

    Pa'iloa0i%+#

    H!%'!# Si'l!

    Mol+#&+ &on"a.io#+$O%,

    8

    8

    8

    8

    8

    8

    8

    8

    8E'#"!in Ba%%$ 1y"o!.alo0i%+#

    H!'a"i"i# B

    AIDS

    Ra*i!#

    Banya2 #'!#i!# EEE

    Banya2 #'!#i!# d!a 2+nin.

  • 8/9/2019 Patogenesis-2

    12/37

    UNTUK MENYEBABKAN PENYAKIT VIRUS HARUS :Ma#+2 R!'li2a#i '%i!% P!ny!*a%an Vi%+# 1!d!%a #!l R!#'on i+n Inan.

    P!*!%#i/an Vi%+#5in,!2#i !n!"a' #!&a%a '!%#i#"!n P!l!'a#an Vi%+#

    INFEKSI VIRUS :# Kon"a2 lan.#+n.# Kon"a2 "a2 lan.#+n.

    BAGANPOLA PATOGENESIS POTENSIAL INFEKSI VIRUS

    In,!2#i 0i%+# '%i!%

    T!'a" lo2ali#a#i

    Vi%+#

    P!nya2i" 'd "!'a"

    lo2ali#a#i5a#i'"oa"i2

    P!ny!*a%an lan.#+n.

    'd 9"a%.!" o%.an#N!%0+# '!%i,!%

    Da%a/Si#"i li,a"i2Ta%.!" o%.an

    Li'a

    Ha"i

    L!2o#i"P!nya2i"

    P!nya2i"

    Da%a/

  • 8/9/2019 Patogenesis-2

    13/37

    PATOGENESIS

    P!a#+2an ; R!'li2a#i P%i!%P!ny!*a%an 0i%+# ; "%o'i#! #!l

    # 0i%+# !ny!*a*2an '!nya2i" 'ada "!'a" yan. 7a+/ da%i "!'a"

    a#+2nya# 0i%+# !'+nyai "%o'i#! "!%/ada' 7a%in.an a"a+ #!l

    R%S%&T'R2/+#+# di'!%+2aan #!l +n"+2 0i%+# (%!#!'"o%2o'on!n '!%+2aan yan. *!%in"!%a2#i #!&a%a 2/+#+# d!n.an

    #+a"+ da!%a/ di'!%+2aan 0i%+# (2a'#id5#!l+*+n.) +n"+2

    !+lai in,!2#i)

    M!li*a"2an ENIM

  • 8/9/2019 Patogenesis-2

    14/37

    1!d!%a #!l dan P!nya2i" 2lini2In,!2#i 0i%+# 2!%+#a2an #!l57a%in.an$ i#alnya : /ilan.nya

    '%od+2#i /o%onE'i"!l +#+# &!'a" %!.!n!%a#i

    O"a2 la*a" %!.!n!%a#i

    P!ny!*+/an

    a2i2a" in,!2#i 0i%+# *i#a "!%7adi 2!a"ian a"a+ #!*+/ !li*a"2ani+ni"a# /+o%al *!%'!%an"a%a #!l$ in"!%,!%on$ li,o2in dan ,a2"o%

    '!%"a/anan lain

    P!l!'a#an 0i%+#*anya2 "!%7adi 'ada "!'a" a#+2 0i%+#

    Vi%+# Ra*i!# "ida2 !n.alai '!l!'a#an ,a"al

  • 8/9/2019 Patogenesis-2

    15/37

    KEMUNGKINAN YANG DAPAT TER6ADI PADA INTERAKSI VIRUS < HOSPES

    #Resistentak terlihat terjadi adanya hubungan

    #Infeksi Subklinik&enyembuhan Infeksi &ersisten

    #&enyakit (kut!KlinikKematian

    Sembuh dengan!Tanpa se)uele

    Sembuh dengan Infeksi *atent!&ersisten

    #Infeksi +enahun Khronik"(simptomatik, *atent

    *atent dengan Rekurensi

    &ersisten dengan &enyakit Khronik

    nfeksi Virus *ambat Slo Virus Infetion"

    #Transformasi +alignan

    #Virus bertindak sebagai .Triger/Reaksi 0ospes tak normal Sindrom

    Reye, Sindrom 1remik 0emolitik

  • 8/9/2019 Patogenesis-2

    16/37

    %ourse of Viral Infection

    #rimary Replication

    ! The place of primary replication is where the virus replicates after

    gaining initial entry into the host.

    ! This frequently determines whether the infection will be locali=ed atthe site of entry or spread to become a systemic infection.

    Systemic Spread

    ! *part from direct celltocell contact' the virus may spread

    via the blood stream and the %7$.

    Secondary Replication

    ! $econdary replication takes place at susceptible organs4tissues

    following systemic spread.

  • 8/9/2019 Patogenesis-2

    17/37

    %ell Tropism

    Viral affinity for specific body tissues 2tropism3 is

    determined by

    ! %ell receptors for virus.

    ! %ell transcription factors that recogni=e viralpromoters and enhancer sequences.

    ! *bility of the cell to support virus replication.

    ! Physical barriers.

    ! ,ocal temperature' p+' and o-ygen tensionen=ymes and nonspecific factors in bodysecretions.

    ! #igestive en=ymes and bile in the gastrointestinaltract that may inactivate some viruses.

  • 8/9/2019 Patogenesis-2

    18/37

    %ell #amage

    Viruses may replicate widely throughout the body without

    any disease symptoms if they do not cause significant cell

    damage or death.

    "etroviruses do not generally cause cell death' being

    released from the cell by budding rather than by cell lysis'

    and cause persistent infections.

    %onversely' Picornaviruses cause lysis and death of the

    cells in which they replicate' leading to fever and increasedmucus secretion in the case of "hinoviruses' paralysis or

    death 2usually due to respiratory failure3 for Poliovirus.

  • 8/9/2019 Patogenesis-2

    19/37

    Immune "esponse

    The immune response to the virus probably has the greatest impact

    on the outcome of infection.

    In the most cases' the virus is cleared completely from the body

    and results in complete recovery.

    In other infections' the immune response is unable to clear the

    virus completely and the virus persists.

    In a number of infections' the immune response plays a major

    pathological role in the disease.

    In general' cellular immunity plays the major role in clearing virus

    infection whereas humoral immunity protects against reinfection.

  • 8/9/2019 Patogenesis-2

    20/37

    Immune Pathological "esponse

    (nhanced viral injury could be due to one or a mi-ture of

    the following mechanisms:

    ! Increased secondary response to Tc cells e.g. +)V! $pecific *#%% or complement mediated cell lysis

    ! )inding of unneutrali=ed virus*b comple-es to cell

    surface 1c receptors' and thus increasing the number

    of cells infected e.g. #engue haemorrhagic fever' +IV.

    ! Immune comple- deposition in organs such as the

    skin' brain or kidney e.g. rash of rubella and measles.

  • 8/9/2019 Patogenesis-2

    21/37

    Viral %learance or Persistence

    The majority of viral infections are cleared but certain

    viruses may cause persistent infections. There are 8

    types of chronic persistent infections.

    True ,atency the virus remains completely latent

    following primary infection e.g. +$V' V>V. Its

    genome may be integrated into the cellular genome or

    e-ists as episomes.

    Persistence the virus replicates continuously in the

    body at a very low level e.g. +IV' +)V' %&V' ()V.

  • 8/9/2019 Patogenesis-2

    22/37

    &echanisms of Viral Persistence

    ! antigenic variation

    ! immune tolerance' causing a reduced response to an antigen' may be dueto genetic factors' prenatal infection' molecular mimicry

    ! restricted gene e-pression

    ! downregulation of &+% class I e-pression' resulting in lack ofrecognition of infected cells e.g. *denoviruses

    ! downregulation of accessory molecules involved in immune recognitione.g. ,1*5 and I%*&/ by ()V.

    ! infection of immunopriviliged sites within the body e.g. +$V in sensoryganglia in the %7$

    ! direct infection of the cells of the immune system itself e.g. +erpesviruses' "etroviruses 2+IV3 often resulting in immunosuppression.

  • 8/9/2019 Patogenesis-2

    23/37

    (-amples of Viral Pathogenesis

  • 8/9/2019 Patogenesis-2

    24/37

    +erpes $imple- Virus

    +$V is spread by contact' as the virus is shed in saliva' tears' genital

    and other secretions.

    Primary infection is usually trivial or subclinical in most individuals.

    It is a disease mainly of very young children ie. those below ? years.

    *bout /@A of the population acquires +$V infection through the

    genital route and the risk is concentrated in young adulthood.

    1ollowing primary infection' B?A of orally infected individuals and

    C@A of patients with genital herpes will e-perience recurrences. The actual frequency of recurrences varies widely between

    individuals. The mean number of episodes per year is about /.C.

  • 8/9/2019 Patogenesis-2

    25/37

    Pathogenesis

    #uring the primary infection' +$V spreads locally and a shortlived

    viraemia occurs' whereby the virus is disseminated in the body. $pread to

    the to craniospinal ganglia occurs.

    The virus then establishes latency in the craniospinal ganglia.

    The e-act mechanism of latency is not known' it may be true latency

    where there is no viral replication or viral persistence where there is a low

    level of viral replication.

    "eactivation * It is well known that many triggers can provoke arecurrence. These include physical or psychological stress' infection:

    especially pneumococcal and meningococcal' fever' irradiation: including

    sunlight' and menstruation.

  • 8/9/2019 Patogenesis-2

    26/37

    AKTIVASI PERIODIK INFEKSI VIRUS HERPES SIMPLE=

    > ? @ 3

    A

    B

    1

    D

    E

    F

    G

    H

    I

    6

    Ga%i# a*an.In,!2#i ini"ial

    S"i+l+#

    A 8 6 In,!2#i %!2+%!n

    > In,!2#i #+*2lini2 (ina''a%!n") &o0!%"

    ? In,!2#i 2lini2 (a''a%!n") o0!%"

    @ In,!2#i la"!n"

    3 In,!2#i 2lini2

    In,!2#i la"!n"

  • 8/9/2019 Patogenesis-2

    27/37

    %linical &anifestations

    +$V is involved in a variety of clinical manifestations

    which includes :

    /. *cute gingivostomatitis

    8. +erpes ,abialis 2cold sore3

    5. cular +erpes

    B. +erpes ;enitalis

    ?. ther forms of cutaneous herpesD. &eningitis

    0. (ncephalitis

    E. 7eonatal herpes

  • 8/9/2019 Patogenesis-2

    28/37

    GAMBARAN PENYAKIT VIRUS AKUT

    INFEKSI LOKAL INFEKSI SISTEMIK

    2ontoh penyakitspesifik

    &ernapasan Rinovirus" 2ampak

    Tempat patologi &intu masukTempat yangberdekatan

    *ama inkubasi Relatif pendek Relatif panjang

    Viremia Tidak ada (da

    *ama imunitas

    3ervariasi, mungkin

    pendek 3iasanya umur panjang

    (b sekretor Ig(" padaresistensi

    penting Tidak penting

  • 8/9/2019 Patogenesis-2

    29/37

    VIRUS ONKOGENIK

    VIRUS DNA :

    PAPOVAVIRIDAEVi%+# PolyoaSiian Vi%+# 34 (SV 34)Vi%+# Pa'iloa K!lin&iVi%+# Pa'iloa Bo0in

    HERPESVIRIDAEVi%+# P!nya2i" Ma%!2Vi%+# Ka%#inoa Kodo2 L+&2!H!%'!#0i%+# Saii%iVi%+# E'#"!in 8 Ba%%Vi%+# H!%'!# Si'l!

    HEPADNAVIRIDAEVi%+# H!'a"i"i# B

    PO=VIRIDAEVi%+# YABAVi%+# Fi*%oa K!lin&i

    VIRUS RNA :

    RETROVIRIDAEVi%+# L!+2!ia M+%inVi%+# F%i!ndVi%+# Maldn!yVi%+# Ra+#&/!%Vi%+# G%o##

    Vi%+# T+o% Maa!Vi%+# AIDS (HTLV III5 LAV$ HIV)

    ( H+an T

  • 8/9/2019 Patogenesis-2

    30/37

    VIRUS DENGAN REAKSI HOSPES YANG LUAR BIASA

    Sind%o R!y! :Vi%+# In,l+!n-aVi%+# Va%i&!lla 8 oo#"!%Vi%+# Pa%ain,l+!n-aP!nya2i" Vi%+# P%odoal yan. "a2 "!%id!n"i,i2a#i R!o0i%+#$ E&/o0i%+#

    1o#a&2i!0i%+#$ Ad!no0i%+#$ H!%'!#0i%+#

    SINDROM HEMOLITIK :1o#a&2i!0i%+#

    Vi%+# 6aninVi%+# E'#"!in 8 Ba%%P!nya2i" Vi%+# P%odoal yan. "a2 "!%id!n"i,i2a#i

  • 8/9/2019 Patogenesis-2

    31/37

    Sind%o G+illain 8 Ba%%! : Vi%+# E'#"!in 8 Ba%%

    Vi%+# 0a2#in In,l+!n-a Ba*i Vi%+# Pa%o"i"i# E'id!i&a

    En&!,alo'a"i Pa#&a In,!2#i : Vi%+# Mo%*ili Vi%+# Va&&inia Vi%+# Va%i&!lla 8 oo#"!% Vi%+# 'a%o"i"i# E'id!i&a

    Mo%*ili A"i'i2 :Vi%+# Mo%*ili 'ada o%an. yan. dii+ni#a#i d!n.an

    Vi%+# 0a2#in Mo%*ili yan. dia"i2an

  • 8/9/2019 Patogenesis-2

    32/37

    BAGAN INFEKSI AKUT DAN MA1AM

  • 8/9/2019 Patogenesis-2

    33/37

    INFEKSI VIRUS PADA SALURAN PERNAPASAN

    Vi%+# P!ny!*a* yan. Palin. S!%in.

    Sind%oa G!7ala U"aa Bayi Ana2

  • 8/9/2019 Patogenesis-2

    34/37

    INFEKSI VIRUS PADA 6ANIN

    Vi%+#

    ani"a Hail yan. P!2a

    A*o%"+#

    S'on"an

    6anin

    No%al

    In,!2#i

    Anion

    In,!2#i

    Pla#!n"a

    In,!2#i 6anin

    In,!2#i Ma"!%nal

    T!l+%

    6anin

    No%al

    6anin T!%in,!2#i

    (

    '!nya2i")

    K!a"ian 6anin

    (A*o%"+#$ la/i% a"i)Mal,o%a#i

    ( a"i)

    In"%a0

    a.in

    a Vi%!ia

  • 8/9/2019 Patogenesis-2

    35/37

    INFEKSI VIRUS PERINATAL

    K!#!%in.an a2"+ In,!2#i

    Vi%+#P%!na"al

    (dala +"!%+#)

    Na"al

    (S!laaP!%#alinan)

    Po#"na"al

    (S!"!la/P!%#alinan)

    In#id!nN!ona"al ('!%

    >444 la/i%/id+')

    R+*!la 8 6a%an. 4$> 8 4$

    1y"o!.alo0i%+# < ?

    H!%'!# Si'l! 4$4@ 8 4$

    Va%i&!lla

  • 8/9/2019 Patogenesis-2

    36/37

    RESPON IMUN TERHADAP BERBAGAI INFEKSI VIRUS

    In"!%,!%on dan I.A P!%"a/anan +"aa 'ada !'i"!l

    '!%+2aan

    Vi%!ia Vi%+# %!n"an "!%/ada' An"i*odi

    Vi%+# di dala #!l Si#"i i+n /+o%al

    Si#"i i+n #!l+l!%

    An"i*odi !lal+i AD11

    P!n./an&+%an 0i%+# di dala #!l M!n.+n"+n.2an

    I+no'a"olo.i2

  • 8/9/2019 Patogenesis-2

    37/37

    $ummary

    Viral Pathogenesis depends on the comple- interplay of a

    large number of viral and host factors.

    Viral factors include cell tropism and cellularpathogenesis.

    The immune response is the most important host factor' as

    it determines whether the virus is cleared or not.

    $ometimes' the immune response itself is responsible for

    the damage.